Khandaker Md Nuruzzaman, Islam Md Mahbubul, Emran Md Ali, Ahmed Badrunnesa, Khan Shoma Farzana, Khasru Moshiur R, Rob Saosun Binta, Yeasmin Sarjana, Ranjan Redoy
Physical Medicine and Rehabilitation, Bangabandhu Sheikh Mujib Medical University, Dhaka, BGD.
Physical Medicine and Rehabilitation, Manikganj Sadar Hospital, Manikganj, BGD.
Cureus. 2023 Feb 5;15(2):e34659. doi: 10.7759/cureus.34659. eCollection 2023 Feb.
Background Plantar fasciitis is the most common cause of foot pain. Patients with plantar fasciitis typically present with 'first step pain,' which tends to decrease with activity and worse with heavy use. This study determines the effect of ultrasound-guided, single-dose, platelet-rich plasma (PRP) injection in patients with chronic plantar fasciitis. Materials and methods It was a quasi-experimental trial carried out in the Department of Physical Medicine and Rehabilitation, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh, from March 2019 to March 2022. A total of 148 patients diagnosed with chronic plantar fasciitis were selected as samples. A total of 75 patients were allocated to group A (intra-lesional injection of autologous PRP with conservative management) and 73 patients to Group B (only conservative management). Both groups of patients were allocated to conservative management with exercises, shoe modification, activities of daily living (ADLs) instruction, and oral paracetamol. Results This study shows that in group A, the mean visual analog scale (VAS) score significantly reduced to 1.47±0.51 after six months of single-dose PRP injection (p<0.001). In group B, the VAS score also decreased substantially after conservative treatment. Though in groups A and B, pain reduction was significant, in group A, the pain was decreased more compared to group B and statistically significant differences were found between the two groups at the 12th week and 24th week. The foot function index (FFI) scores decreased significantly in group A after a single dose PRP injection, compared with group B treated with conventional therapy. In group A, FFI scores decreased from 49.09±5.72 to 7.67±3.41. The study revealed a significant difference between study groups in the 12th week and 24th week regarding FFI scores. Conclusion Ultrasound-guided intra-lesional autologous PRP Injection is safe and effective and recommended in patients with chronic plantar fasciitis, especially in recalcitrant cases after the failure of conservative treatment and corticosteroid injection.
背景 足底筋膜炎是足部疼痛最常见的原因。足底筋膜炎患者通常表现为“起步痛”,活动后疼痛往往减轻,过度使用则加重。本研究确定超声引导下单剂量富血小板血浆(PRP)注射对慢性足底筋膜炎患者的疗效。
材料与方法 这是一项在孟加拉国达卡班加班德谢赫穆吉布医科大学(BSMMU)物理医学与康复科进行的准实验性试验,时间从2019年3月至2022年3月。共选取148例诊断为慢性足底筋膜炎的患者作为样本。75例患者被分配到A组(病灶内注射自体PRP并辅以保守治疗),73例患者被分配到B组(仅进行保守治疗)。两组患者均接受包括运动、鞋具改良、日常生活活动(ADL)指导以及口服扑热息痛在内的保守治疗。
结果 本研究表明,A组在单剂量PRP注射6个月后,平均视觉模拟量表(VAS)评分显著降至1.47±0.51(p<0.001)。B组在保守治疗后VAS评分也大幅下降。虽然A组和B组的疼痛均有显著减轻,但A组的疼痛减轻程度比B组更大,且在第12周和第24周时两组间存在统计学显著差异。与接受传统治疗的B组相比,A组在单剂量PRP注射后足部功能指数(FFI)评分显著降低。A组的FFI评分从49.09±5.72降至7.67±3.41。研究显示,在第12周和第24周时,两组在FFI评分方面存在显著差异。
结论 超声引导下病灶内自体PRP注射安全有效,推荐用于慢性足底筋膜炎患者,尤其是保守治疗和皮质类固醇注射失败后的顽固性病例。